Journal
Scientific Reports
Volume 6, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/srep31074
Keywords
-
Categories
Funding
- National Major Project [2013ZX09103001-001]
- International Science &Technology Cooperation Program of China [2014DFA31130]
- National Natural Science Foundation of China [81302699, 81273435]
- China Postdoctoral Science Foundation [2014T70444]
- State Key Laboratory of Drug Research [SIMM1501KF-07]
- Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase)
Ask authors/readers for more resources
Drug repositioning has been attracting increasingly attention for its advantages of reducing costs and risks. Statistics showed that around one quarter of the marketed drugs are organohalogens. However, no study has been reported, to the best of our knowledge, to aim at efficiently repositioning organohalogen drugs, which may be attributed to the lack of accurate halogen bonding scoring function. Here, we present a study to show that two organohalogen drugs were successfully repositioned as potent B-Raf V600E inhibitors via molecular docking with halogen bonding scoring function, namely D(3)DOCKxb developed in our lab, and bioassay. After virtual screening by D(3)DOCKxb against the database CMC (Comprehensive Medicinal Chemistry), 3 organohalogen drugs that were predicted to form strong halogen bonding with B-Raf V600E were purchased and tested with ELISA-based assay. In the end, 2 of them, rafoxanide and closantel, were identified as potent inhibitors with IC50 values of 0.07 mu M and 1.90 mu M, respectively, which are comparable to that of vemurafenib (IC50: 0.17 mu M), a marketed drug targeting B-Raf V600E. Single point mutagenesis experiments confirmed the conformations predicted by D(3)DOCKxb. And comparison experiment revealed that halogen bonding scoring function is essential for repositioning those drugs with heavy halogen atoms in their molecular structures.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available